Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid-Related Disorders × Sublocade × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Opioid-Related Disorders 1 Lymphoma, Follicular 1

Interventions

Ultrasonic Waves 1 Tirzepatide 1 Therapeutics 1 Sublocade 1 Standard of Care 1 Psilocybin 1 Olanzapine 1 Midazolam 1 Lidocaine 1 Educational Status 1 Dosage Forms 1 Buprenorphine, Naloxone Drug Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04060654 2025-03-25

SUBLOCADE Rapid Initiation Extension Study

Indivior Inc.

Phase 4 Completed

17 enrolled 12 charts

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡